Lv1
2 积分 2025-12-10 加入
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults
11天前
已完结
SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases
12天前
已完结
SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled study
13天前
已完结
New Triazacycloalkane Derivatives as Cytotoxic Agents for CLL Treatment: From Proof of Concept to the Targeting Biomolecule
3个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
3个月前
已完结
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapy
3个月前
已完结
Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss
4个月前
已完结
CAR T-cell therapy in autoimmune diseases
4个月前
已完结
皖公网安备34019202002308
